MedTrace Logo

The Dynamics of Human Atrial Fibrillation

NCT01008722 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 98

Last updated 2017-02-08

Study results available
· View outcomes & findings →

Summary

The study is conducted in patients with atrial fibrillation undergoing clinically prescribed ablation. The study hypothesis is that ablation at specific sites that are identified to 'drive' the atrial fibrillation may improve the success of the ablation procedure.

Conditions

Sponsors & Collaborators

Principal Investigators

  • Sanjiv M. Narayan, MD, PhD · University of California, San Diego

Eligibility

Min Age
21 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2009-06-30
Primary Completion
2014-04-30
Completion
2014-05-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01008722 on ClinicalTrials.gov